Alise Reicin insider trades: Tectonic Therapeutic (TECX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alise reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | TECX | ↑ Buy | 2,500 | $21.10 | $53K | By Trust | Mar 5, 2026 (22d) |
| Feb 11, 2026 | TECX | ↑ Buy | 2,500 | $21.10 | $53K | Direct | Feb 12, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TECX insiders
Open-market trades in the last 12 months
About Alise Reicin's insider trades
Alise Reicin is Chief Executive Officer at Tectonic Therapeutic (TECX). Since Feb 11, 2026, Alise has reported 2 open-market purchases worth $106K and no sales on SEC Form 4. In the last 12 months: 2 buys ($106K).
Their filings also include grants and awards (20 filings), shares withheld for taxes (5 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TECX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.